RWPA
LLY icon

Richard W. Paul & Associates’s Eli Lilly LLY Stock Holding History

Richard W. Paul & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Sell
1,221
-46
-4% -$47K 0.45% 59
2026
Q1 		$1.17M Sell
1,267
-6
-0.5% -$6.08K 0.39% 73
2025
Q4 		$1.37M Sell
1,273
-125
-9% -$120K 0.45% 58
2025
Q3 		$1.07M Buy
1,398
+173
+14% +$129K 0.36% 71
2025
Q2 		$955K Buy
1,225
+61
+5% +$47.4K 0.35% 72
2025
Q1 		$961K Buy
1,164
+1
+0.1% +$832 0.38% 65
2024
Q4 		$898K Buy
1,163
+136
+13% +$113K 0.33% 83
2024
Q3 		$910K Sell
1,027
-29
-3% -$26.1K 0.33% 90
2024
Q2 		$956K Sell
1,056
-38
-3% -$30.4K 0.37% 70
2024
Q1 		$851K Sell
1,094
-73
-6% -$52K 0.34% 79
2023
Q4 		$680K Buy
1,167
+257
+28% +$150K 0.29% 94
2023
Q3 		$489K Sell
910
-339
-27% -$175K 0.22% 104
2023
Q2 		$586K Buy
1,249
+1
+0.1% +$419 0.26% 104
2023
Q1 		$428K Buy
1,248
+28
+2% +$9.44K 0.2% 113
2022
Q4 		$446K Buy
+1,220
New +$433K 0.22% 103

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Richard W. Paul & Associates's LLY Position: Q2 2026 in Review

Richard W. Paul & Associates reduced its Eli Lilly (LLY) stake by 3.6% in Q2 2026, selling an estimated $47K and leaving 1,221 shares worth $1.46M. The position accounts for 0.45% of the portfolio, ranked #59.

Richard W. Paul & Associates first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Richard W. Paul & Associates held 1,221 shares of Eli Lilly worth $1.46M as of Q2 2026.
  • Richard W. Paul & Associates sold 46 Eli Lilly shares in Q2 2026, an estimated $47K.
  • Eli Lilly made up 0.45% of Richard W. Paul & Associates's portfolio in Q2 2026, its #59 holding.
  • Richard W. Paul & Associates first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Richard W. Paul & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.